Serious adverse events
|
Placebo |
Dulaglutide |
Total subjects affected by serious adverse events
|
|
|
subjects affected / exposed
|
2044 / 4949 (41.30%) |
1991 / 4943 (40.28%) |
number of deaths (all causes)
|
277 |
242 |
number of deaths resulting from adverse events
|
13 |
8 |
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
|
|
|
acute myeloid leukaemia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
adenocarcinoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
adenocarcinoma gastric
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
10 / 4949 (0.20%) |
7 / 4943 (0.14%) |
occurrences causally related to treatment / all
|
1 / 11 |
1 / 7 |
deaths causally related to treatment / all
|
1 / 4 |
0 / 1 |
adenocarcinoma of colon
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
14 / 4949 (0.28%) |
17 / 4943 (0.34%) |
occurrences causally related to treatment / all
|
1 / 14 |
1 / 17 |
deaths causally related to treatment / all
|
0 / 1 |
1 / 4 |
adenocarcinoma of the cervix
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed [1]
|
1 / 2282 (0.04%) |
1 / 2303 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
adenocarcinoma pancreas
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
4 / 4943 (0.08%) |
occurrences causally related to treatment / all
|
0 / 0 |
2 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
1 / 2 |
adenoma benign
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
adenosquamous cell carcinoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
adrenal adenoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
adrenal neoplasm
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
1 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
anal squamous cell carcinoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
anaplastic astrocytoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
anogenital warts
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
astrocytoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
b-cell lymphoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
1 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
b-cell lymphoma stage i
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
b-cell lymphoma stage ii
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
b-cell small lymphocytic lymphoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
basal cell carcinoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
11 / 4949 (0.22%) |
7 / 4943 (0.14%) |
occurrences causally related to treatment / all
|
0 / 11 |
0 / 7 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
benign gastric neoplasm
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
benign hepatic neoplasm
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
benign neoplasm of adrenal gland
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
benign neoplasm of thyroid gland
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
bile duct adenocarcinoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
bile duct cancer
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
biliary cancer metastatic
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
bladder cancer
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
6 / 4949 (0.12%) |
5 / 4943 (0.10%) |
occurrences causally related to treatment / all
|
0 / 6 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
bladder cancer recurrent
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
bladder neoplasm
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
1 / 5 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
bladder papilloma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
bladder transitional cell carcinoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
6 / 4949 (0.12%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
1 / 6 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 2 |
0 / 0 |
bladder transitional cell carcinoma recurrent
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
bladder transitional cell carcinoma stage i
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
bone cancer
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
bone cancer metastatic
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
bone neoplasm
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
borderline ovarian tumour
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed [2]
|
0 / 2282 (0.00%) |
1 / 2303 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
bowen's disease
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
brain neoplasm
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 2 |
0 / 0 |
brain neoplasm malignant
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
breast cancer
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
8 / 4949 (0.16%) |
11 / 4943 (0.22%) |
occurrences causally related to treatment / all
|
0 / 8 |
1 / 11 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
breast cancer metastatic
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 3 |
1 / 2 |
deaths causally related to treatment / all
|
0 / 2 |
0 / 1 |
breast cancer recurrent
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
breast cancer stage iii
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
brenner tumour
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed [3]
|
0 / 2282 (0.00%) |
1 / 2303 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
bronchial carcinoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
cancer pain
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
carcinoid tumour pulmonary
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
cardiac myxoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
cerebral haemangioma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
cervix carcinoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed [4]
|
2 / 2282 (0.09%) |
4 / 2303 (0.17%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
cervix carcinoma stage 0
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed [5]
|
2 / 2282 (0.09%) |
0 / 2303 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
cholangiocarcinoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
4 / 4943 (0.08%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
chronic lymphocytic leukaemia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
4 / 4943 (0.08%) |
occurrences causally related to treatment / all
|
0 / 1 |
1 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
chronic myeloid leukaemia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
clear cell renal cell carcinoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
6 / 4943 (0.12%) |
occurrences causally related to treatment / all
|
0 / 3 |
1 / 6 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
colon adenoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
8 / 4949 (0.16%) |
5 / 4943 (0.10%) |
occurrences causally related to treatment / all
|
0 / 9 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
colon cancer
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
6 / 4943 (0.12%) |
occurrences causally related to treatment / all
|
2 / 5 |
0 / 6 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 2 |
colon cancer metastatic
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
colon cancer stage ii
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
colon cancer stage iv
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
colon neoplasm
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
colorectal adenocarcinoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
colorectal cancer
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
2 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
colorectal cancer metastatic
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
diffuse large b-cell lymphoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
diffuse large b-cell lymphoma stage iv
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
ductal adenocarcinoma of pancreas
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
endometrial adenocarcinoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed [6]
|
9 / 2282 (0.39%) |
6 / 2303 (0.26%) |
occurrences causally related to treatment / all
|
1 / 9 |
0 / 7 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
endometrial cancer
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed [7]
|
1 / 2282 (0.04%) |
3 / 2303 (0.13%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
extranodal marginal zone b-cell lymphoma (malt type)
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
fibroadenoma of breast
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
fibrosarcoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
gallbladder cancer metastatic
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
gallbladder squamous cell carcinoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
gastric cancer
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
6 / 4943 (0.12%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 6 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 3 |
gastric neoplasm
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
1 / 3 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
gastrointestinal stromal cancer
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
gastrointestinal stromal tumour
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
glioblastoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
hepatic angiosarcoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
1 / 1 |
hepatic cancer
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 3 |
0 / 0 |
hepatic cancer metastatic
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
1 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
hepatic neoplasm
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
hepatocellular carcinoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
6 / 4949 (0.12%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
3 / 6 |
0 / 1 |
deaths causally related to treatment / all
|
2 / 2 |
0 / 1 |
hodgkin's disease
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
huerthle cell carcinoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
intraductal proliferative breast lesion
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
invasive breast carcinoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
invasive ductal breast carcinoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
11 / 4949 (0.22%) |
7 / 4943 (0.14%) |
occurrences causally related to treatment / all
|
0 / 11 |
0 / 7 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
invasive lobular breast carcinoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
keratoacanthoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
large intestine benign neoplasm
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
laryngeal cancer
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
laryngeal squamous cell carcinoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
leiomyosarcoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
leiomyosarcoma metastatic
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
lip squamous cell carcinoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
lipoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
liposarcoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
liposarcoma metastatic
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
lung adenocarcinoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
8 / 4949 (0.16%) |
6 / 4943 (0.12%) |
occurrences causally related to treatment / all
|
0 / 8 |
0 / 7 |
deaths causally related to treatment / all
|
0 / 2 |
0 / 1 |
lung adenocarcinoma stage ii
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
lung adenocarcinoma stage iii
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
lung adenocarcinoma stage iv
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
lung cancer metastatic
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
lung neoplasm
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
lung neoplasm malignant
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
6 / 4949 (0.12%) |
9 / 4943 (0.18%) |
occurrences causally related to treatment / all
|
1 / 6 |
0 / 9 |
deaths causally related to treatment / all
|
1 / 4 |
0 / 3 |
lymphoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
malignant joint neoplasm
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
malignant melanoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
5 / 4943 (0.10%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
malignant melanoma stage iii
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
malignant neoplasm of ampulla of vater
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
malignant pleural effusion
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
mediastinum neoplasm
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
medullary thyroid cancer
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
meningeal neoplasm
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
meningioma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
mesothelioma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
mesothelioma malignant
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
metastases to adrenals
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
metastases to bone
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
metastases to central nervous system
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
metastases to chest wall
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
metastases to kidney
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
metastases to liver
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
7 / 4943 (0.14%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 7 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
metastases to lung
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
6 / 4949 (0.12%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 6 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
metastases to lymph nodes
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
metastases to pelvis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
metastases to peritoneum
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
metastases to pleura
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
metastatic bronchial carcinoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
1 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
1 / 1 |
0 / 1 |
metastatic gastric cancer
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
metastatic neoplasm
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 3 |
0 / 0 |
metastatic renal cell carcinoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
myelodysplastic syndrome
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
nasal sinus cancer
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
neoplasm
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
neoplasm malignant
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
neoplasm prostate
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed [8]
|
0 / 2667 (0.00%) |
3 / 2640 (0.11%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
neuroendocrine carcinoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
1 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
neuroendocrine carcinoma of the skin
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
neuroendocrine tumour
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
1 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
non-hodgkin's lymphoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
1 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
non-small cell lung cancer
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
non-small cell lung cancer metastatic
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
non-small cell lung cancer stage ii
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
non-small cell lung cancer stage iv
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
oesophageal adenocarcinoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
oesophageal carcinoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 2 |
oesophageal squamous cell carcinoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
ovarian adenoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed [9]
|
2 / 2282 (0.09%) |
0 / 2303 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
ovarian cancer
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed [10]
|
2 / 2282 (0.09%) |
0 / 2303 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
ovarian cancer metastatic
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed [11]
|
1 / 2282 (0.04%) |
0 / 2303 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
ovarian cancer stage iii
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed [12]
|
1 / 2282 (0.04%) |
0 / 2303 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
ovarian epithelial cancer
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed [13]
|
0 / 2282 (0.00%) |
2 / 2303 (0.09%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
pancreatic carcinoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
8 / 4943 (0.16%) |
occurrences causally related to treatment / all
|
0 / 5 |
1 / 8 |
deaths causally related to treatment / all
|
0 / 2 |
0 / 1 |
pancreatic carcinoma metastatic
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
4 / 4943 (0.08%) |
occurrences causally related to treatment / all
|
3 / 5 |
3 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
1 / 2 |
pancreatic neoplasm
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 2 |
papillary thyroid cancer
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
4 / 4943 (0.08%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
paraganglion neoplasm
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
parathyroid tumour benign
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
penile squamous cell carcinoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed [14]
|
1 / 2667 (0.04%) |
0 / 2640 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
pericardial effusion malignant
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
phaeochromocytoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
pituitary tumour
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
pituitary tumour benign
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
plasma cell leukaemia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
plasma cell myeloma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
5 / 4943 (0.10%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 6 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 2 |
prostate cancer
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed [15]
|
33 / 2667 (1.24%) |
33 / 2640 (1.25%) |
occurrences causally related to treatment / all
|
1 / 34 |
1 / 33 |
deaths causally related to treatment / all
|
0 / 2 |
0 / 0 |
prostate cancer metastatic
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed [16]
|
4 / 2667 (0.15%) |
2 / 2640 (0.08%) |
occurrences causally related to treatment / all
|
1 / 4 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 2 |
prostate cancer recurrent
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed [17]
|
1 / 2667 (0.04%) |
1 / 2640 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
prostate cancer stage i
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed [18]
|
1 / 2667 (0.04%) |
0 / 2640 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
prostatic adenoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed [19]
|
3 / 2667 (0.11%) |
6 / 2640 (0.23%) |
occurrences causally related to treatment / all
|
0 / 3 |
1 / 6 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
rectal adenocarcinoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
4 / 4943 (0.08%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
rectal adenoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
rectal cancer
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
1 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
rectal cancer metastatic
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
rectal neoplasm
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
rectosigmoid cancer
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
renal cancer
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
5 / 4943 (0.10%) |
occurrences causally related to treatment / all
|
0 / 4 |
1 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
renal cancer metastatic
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
renal cell carcinoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
7 / 4949 (0.14%) |
4 / 4943 (0.08%) |
occurrences causally related to treatment / all
|
0 / 7 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
renal neoplasm
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 3 |
1 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
renal oncocytoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
sarcoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
small cell lung cancer
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
6 / 4943 (0.12%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 6 |
deaths causally related to treatment / all
|
0 / 2 |
0 / 2 |
small cell lung cancer metastatic
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
spinal meningioma benign
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
spindle cell sarcoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
squamous cell carcinoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
4 / 4943 (0.08%) |
occurrences causally related to treatment / all
|
0 / 1 |
1 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
squamous cell carcinoma of lung
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
7 / 4949 (0.14%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 8 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 2 |
squamous cell carcinoma of skin
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
squamous cell carcinoma of the cervix
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed [20]
|
0 / 2282 (0.00%) |
1 / 2303 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
squamous cell carcinoma of the vagina
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed [21]
|
0 / 2282 (0.00%) |
1 / 2303 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
squamous cell carcinoma of the vulva
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed [22]
|
0 / 2282 (0.00%) |
2 / 2303 (0.09%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
sweat gland tumour
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
throat cancer
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
1 / 1 |
0 / 0 |
thymoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
thyroid adenoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
thyroid cancer
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
tongue carcinoma stage iv
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
tongue neoplasm malignant stage unspecified
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
tonsil cancer
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
transitional cell cancer of the renal pelvis and ureter
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
transitional cell carcinoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
7 / 4943 (0.14%) |
occurrences causally related to treatment / all
|
0 / 3 |
1 / 7 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
transitional cell carcinoma recurrent
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
tumour associated fever
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
tumour of ampulla of vater
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
urethral cancer
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
uterine cancer
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed [23]
|
2 / 2282 (0.09%) |
4 / 2303 (0.17%) |
occurrences causally related to treatment / all
|
1 / 2 |
0 / 4 |
deaths causally related to treatment / all
|
1 / 1 |
0 / 1 |
uterine leiomyoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed [24]
|
1 / 2282 (0.04%) |
3 / 2303 (0.13%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
uterine neoplasm
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed [25]
|
1 / 2282 (0.04%) |
1 / 2303 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
vascular neoplasm
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Vascular disorders
|
|
|
angiodysplasia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
aortic aneurysm
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
10 / 4943 (0.20%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 10 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 2 |
aortic aneurysm rupture
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
aortic arteriosclerosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
aortic dissection
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
aortic stenosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
16 / 4949 (0.32%) |
21 / 4943 (0.42%) |
occurrences causally related to treatment / all
|
0 / 17 |
0 / 21 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
arterial occlusive disease
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
arterial stenosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
arteriosclerosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
1 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
bleeding varicose vein
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
circulatory collapse
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
6 / 4949 (0.12%) |
4 / 4943 (0.08%) |
occurrences causally related to treatment / all
|
0 / 6 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 2 |
0 / 3 |
deep vein thrombosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
10 / 4949 (0.20%) |
16 / 4943 (0.32%) |
occurrences causally related to treatment / all
|
0 / 10 |
0 / 16 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
dry gangrene
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
essential hypertension
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
extremity necrosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
haematoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
4 / 4943 (0.08%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
haemodynamic instability
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
haemorrhage
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
hypertension
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
27 / 4949 (0.55%) |
22 / 4943 (0.45%) |
occurrences causally related to treatment / all
|
0 / 29 |
0 / 24 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
hypertensive crisis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
21 / 4949 (0.42%) |
14 / 4943 (0.28%) |
occurrences causally related to treatment / all
|
0 / 21 |
1 / 14 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
hypertensive emergency
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
4 / 4943 (0.08%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
hypotension
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
7 / 4949 (0.14%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
2 / 7 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
hypovolaemic shock
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
iliac artery embolism
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
intermittent claudication
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
lymphatic fistula
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
lymphoedema
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
neurogenic shock
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
orthostatic hypotension
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
6 / 4943 (0.12%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 6 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
peripheral arterial occlusive disease
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
25 / 4949 (0.51%) |
17 / 4943 (0.34%) |
occurrences causally related to treatment / all
|
0 / 26 |
0 / 18 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
peripheral artery occlusion
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
8 / 4943 (0.16%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 9 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
peripheral artery stenosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
peripheral artery thrombosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
peripheral embolism
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
peripheral ischaemia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
8 / 4949 (0.16%) |
9 / 4943 (0.18%) |
occurrences causally related to treatment / all
|
0 / 9 |
0 / 13 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
peripheral vascular disorder
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
7 / 4949 (0.14%) |
8 / 4943 (0.16%) |
occurrences causally related to treatment / all
|
0 / 8 |
0 / 8 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
peripheral venous disease
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
phlebitis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
shock
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
shock haemorrhagic
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
subclavian artery stenosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
superior vena cava syndrome
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
temporal arteritis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
thrombophlebitis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
thrombosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
varicose vein
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
vena cava thrombosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
venous thrombosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
venous thrombosis limb
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
General disorders and administration site conditions
|
|
|
adverse drug reaction
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
asthenia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
5 / 4943 (0.10%) |
occurrences causally related to treatment / all
|
1 / 5 |
0 / 6 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
chest discomfort
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
chest pain
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
14 / 4949 (0.28%) |
7 / 4943 (0.14%) |
occurrences causally related to treatment / all
|
1 / 15 |
1 / 7 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
death
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
9 / 4949 (0.18%) |
9 / 4943 (0.18%) |
occurrences causally related to treatment / all
|
1 / 9 |
1 / 9 |
deaths causally related to treatment / all
|
1 / 9 |
1 / 9 |
device intolerance
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
drug effect increased
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
drug intolerance
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
fatigue
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
gait disturbance
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
general physical health deterioration
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
4 / 4943 (0.08%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
generalised oedema
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
hernia perforation
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
hyperthermia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
impaired healing
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
4 / 4943 (0.08%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
inflammation
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
malaise
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
metaplasia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
multiple organ dysfunction syndrome
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
5 / 4943 (0.10%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 4 |
0 / 3 |
necrosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
non-cardiac chest pain
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
37 / 4949 (0.75%) |
26 / 4943 (0.53%) |
occurrences causally related to treatment / all
|
0 / 44 |
1 / 28 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
oedema peripheral
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
7 / 4949 (0.14%) |
4 / 4943 (0.08%) |
occurrences causally related to treatment / all
|
0 / 7 |
1 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
pain
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
peripheral swelling
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
pyrexia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
7 / 4949 (0.14%) |
7 / 4943 (0.14%) |
occurrences causally related to treatment / all
|
0 / 7 |
0 / 7 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
strangulated hernia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
sudden cardiac death
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 2 |
0 / 0 |
sudden death
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 5 |
0 / 3 |
systemic inflammatory response syndrome
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
vascular stent occlusion
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
vascular stent stenosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Immune system disorders
|
|
|
anaphylactic reaction
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
anti-neutrophil cytoplasmic antibody positive vasculitis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
contrast media allergy
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
drug hypersensitivity
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
hypersensitivity
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
immunodeficiency
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
sarcoidosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Social circumstances
|
|
|
diet noncompliance
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
organ donor
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Reproductive system and breast disorders
|
|
|
acquired phimosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
benign prostatic hyperplasia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed [26]
|
18 / 2667 (0.67%) |
21 / 2640 (0.80%) |
occurrences causally related to treatment / all
|
1 / 20 |
0 / 21 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
breast pain
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
cervical polyp
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed [27]
|
1 / 2282 (0.04%) |
2 / 2303 (0.09%) |
occurrences causally related to treatment / all
|
0 / 1 |
1 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
cystocele
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed [28]
|
4 / 2282 (0.18%) |
3 / 2303 (0.13%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
endometrial hyperplasia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed [29]
|
0 / 2282 (0.00%) |
1 / 2303 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
endometrial hypertrophy
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed [30]
|
0 / 2282 (0.00%) |
1 / 2303 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
endometriosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed [31]
|
0 / 2282 (0.00%) |
1 / 2303 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
erectile dysfunction
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed [32]
|
1 / 2667 (0.04%) |
0 / 2640 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
female genital tract fistula
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed [33]
|
0 / 2282 (0.00%) |
2 / 2303 (0.09%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
fibrocystic breast disease
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
genital prolapse
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
gynaecomastia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed [34]
|
0 / 2667 (0.00%) |
2 / 2640 (0.08%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
metrorrhagia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed [35]
|
0 / 2282 (0.00%) |
2 / 2303 (0.09%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
ovarian cyst
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed [36]
|
1 / 2282 (0.04%) |
6 / 2303 (0.26%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 6 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
pelvic fluid collection
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
pelvic prolapse
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
prostatism
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed [37]
|
2 / 2667 (0.07%) |
0 / 2640 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
prostatitis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed [38]
|
2 / 2667 (0.07%) |
4 / 2640 (0.15%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
prostatomegaly
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed [39]
|
1 / 2667 (0.04%) |
0 / 2640 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
rectocele
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed [40]
|
1 / 2282 (0.04%) |
1 / 2303 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
uterine disorder
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed [41]
|
0 / 2282 (0.00%) |
1 / 2303 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
uterine polyp
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed [42]
|
2 / 2282 (0.09%) |
3 / 2303 (0.13%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
uterine prolapse
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed [43]
|
0 / 2282 (0.00%) |
3 / 2303 (0.13%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
uterovaginal prolapse
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed [44]
|
2 / 2282 (0.09%) |
2 / 2303 (0.09%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
vaginal haemorrhage
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed [45]
|
1 / 2282 (0.04%) |
1 / 2303 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
vaginal polyp
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed [46]
|
1 / 2282 (0.04%) |
0 / 2303 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
vaginal prolapse
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed [47]
|
0 / 2282 (0.00%) |
2 / 2303 (0.09%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Respiratory, thoracic and mediastinal disorders
|
|
|
acquired diaphragmatic eventration
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
acute pulmonary oedema
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
4 / 4943 (0.08%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
acute respiratory failure
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
17 / 4949 (0.34%) |
6 / 4943 (0.12%) |
occurrences causally related to treatment / all
|
0 / 17 |
0 / 7 |
deaths causally related to treatment / all
|
0 / 4 |
0 / 1 |
alveolitis allergic
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
asphyxia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
aspiration
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
1 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
asthma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
8 / 4949 (0.16%) |
8 / 4943 (0.16%) |
occurrences causally related to treatment / all
|
0 / 13 |
0 / 8 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
atelectasis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
bronchial hyperreactivity
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
bronchial polyp
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
bronchitis chronic
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
bronchopneumopathy
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
chronic obstructive pulmonary disease
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
35 / 4949 (0.71%) |
25 / 4943 (0.51%) |
occurrences causally related to treatment / all
|
0 / 45 |
0 / 32 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
chronic respiratory failure
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
cough
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
dysphonia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
dyspnoea
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
15 / 4949 (0.30%) |
11 / 4943 (0.22%) |
occurrences causally related to treatment / all
|
0 / 15 |
0 / 12 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
dyspnoea exertional
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
6 / 4949 (0.12%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 6 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
emphysema
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
epistaxis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
5 / 4943 (0.10%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
haemoptysis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
haemothorax
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
hypercapnia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
hyperventilation
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
hypoxia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
interstitial lung disease
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
7 / 4949 (0.14%) |
13 / 4943 (0.26%) |
occurrences causally related to treatment / all
|
0 / 7 |
0 / 14 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
lung disorder
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
lung infiltration
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
nasal polyps
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
nasal septum deviation
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
obstructive airways disorder
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
pharyngeal haemorrhage
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
pickwickian syndrome
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
pleural effusion
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
8 / 4949 (0.16%) |
13 / 4943 (0.26%) |
occurrences causally related to treatment / all
|
0 / 10 |
0 / 13 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
pleural thickening
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
pleurisy
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
pneumonia aspiration
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
pneumonitis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
pneumothorax
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
6 / 4949 (0.12%) |
4 / 4943 (0.08%) |
occurrences causally related to treatment / all
|
1 / 6 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
pneumothorax spontaneous
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
pulmonary congestion
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
pulmonary embolism
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
21 / 4949 (0.42%) |
22 / 4943 (0.45%) |
occurrences causally related to treatment / all
|
1 / 22 |
1 / 23 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 5 |
pulmonary fibrosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
pulmonary hypertension
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
pulmonary mass
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
4 / 4943 (0.08%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
pulmonary oedema
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
20 / 4949 (0.40%) |
6 / 4943 (0.12%) |
occurrences causally related to treatment / all
|
0 / 20 |
1 / 6 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
pulmonary thrombosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
respiratory arrest
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
respiratory distress
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
respiratory failure
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
20 / 4949 (0.40%) |
16 / 4943 (0.32%) |
occurrences causally related to treatment / all
|
0 / 22 |
0 / 16 |
deaths causally related to treatment / all
|
0 / 6 |
0 / 5 |
respiratory tract oedema
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
restrictive pulmonary disease
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
rhinitis hypertrophic
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
sleep apnoea syndrome
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
6 / 4949 (0.12%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 6 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Psychiatric disorders
|
|
|
abnormal behaviour
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
adjustment disorder
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
adjustment disorder with depressed mood
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
affective disorder
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
aggression
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
alcohol abuse
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
alcohol withdrawal syndrome
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
anxiety
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
anxiety disorder
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
bipolar disorder
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
confusional state
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
7 / 4949 (0.14%) |
9 / 4943 (0.18%) |
occurrences causally related to treatment / all
|
0 / 7 |
0 / 9 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
delirium
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
8 / 4949 (0.16%) |
10 / 4943 (0.20%) |
occurrences causally related to treatment / all
|
0 / 10 |
0 / 10 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
delusion
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
depression
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
7 / 4949 (0.14%) |
6 / 4943 (0.12%) |
occurrences causally related to treatment / all
|
0 / 8 |
1 / 6 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
depression suicidal
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
disorientation
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
emotional distress
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
generalised anxiety disorder
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
hypomania
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
major depression
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
mania
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
mental disorder
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
mental status changes
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
panic disorder
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
personality change due to a general medical condition
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
psychogenic seizure
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
psychotic disorder
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
restlessness
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
somatic delusion
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
somatic symptom disorder
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
suicidal ideation
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
suicide attempt
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Product issues
|
|
|
device damage
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
device dislocation
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
device failure
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
device loosening
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
device malfunction
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
device occlusion
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Hepatobiliary disorders
|
|
|
acute hepatic failure
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
bile duct obstruction
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
bile duct stenosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
bile duct stone
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
7 / 4949 (0.14%) |
8 / 4943 (0.16%) |
occurrences causally related to treatment / all
|
1 / 7 |
0 / 8 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
biliary colic
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
1 / 1 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
biliary dyspepsia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
cholangitis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
6 / 4943 (0.12%) |
occurrences causally related to treatment / all
|
0 / 2 |
2 / 6 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
cholangitis acute
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
cholangitis chronic
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
cholecystitis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
15 / 4949 (0.30%) |
25 / 4943 (0.51%) |
occurrences causally related to treatment / all
|
0 / 15 |
6 / 28 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
cholecystitis acute
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
17 / 4949 (0.34%) |
26 / 4943 (0.53%) |
occurrences causally related to treatment / all
|
0 / 17 |
4 / 27 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
cholecystitis chronic
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
7 / 4943 (0.14%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 7 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
cholelithiasis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
49 / 4949 (0.99%) |
42 / 4943 (0.85%) |
occurrences causally related to treatment / all
|
2 / 51 |
8 / 43 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
cholestasis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
1 / 3 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
drug-induced liver injury
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
gallbladder cholesterolosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
gallbladder necrosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
gallbladder perforation
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
gallbladder polyp
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
hepatic cirrhosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
5 / 4943 (0.10%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
hepatic failure
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
hepatic mass
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
hepatic steatosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
hepatitis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
2 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
hepatorenal syndrome
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
ischaemic hepatitis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
jaundice
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
jaundice cholestatic
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
liver disorder
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
non-alcoholic fatty liver
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
non-alcoholic steatohepatitis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
portal hypertension
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
portal vein thrombosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
post cholecystectomy syndrome
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Investigations
|
|
|
amylase increased
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
anticoagulation drug level above therapeutic
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
blood calcitonin increased
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
blood calcium increased
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
blood creatinine increased
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
blood glucose decreased
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
blood glucose fluctuation
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
blood glucose increased
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
5 / 4943 (0.10%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 6 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
blood pressure increased
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
c-reactive protein increased
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
coagulation test abnormal
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
electrocardiogram abnormal
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
gamma-glutamyltransferase increased
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
glomerular filtration rate decreased
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
glycosylated haemoglobin increased
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
1 / 2 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
haemoglobin decreased
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
hepatic enzyme increased
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
oxygen saturation decreased
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
transaminases increased
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
troponin t increased
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
troponin increased
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
urine albumin/creatinine ratio increased
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
weight decreased
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
1 / 4 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Injury, poisoning and procedural complications
|
|
|
accident
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
accident at work
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
accidental overdose
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
8 / 4943 (0.16%) |
occurrences causally related to treatment / all
|
0 / 2 |
1 / 8 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
acetabulum fracture
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
alcohol poisoning
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
anaemia postoperative
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
anastomotic complication
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
anastomotic leak
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
ankle fracture
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
20 / 4949 (0.40%) |
21 / 4943 (0.42%) |
occurrences causally related to treatment / all
|
0 / 20 |
0 / 21 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
arterial injury
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
arteriovenous fistula occlusion
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
arthropod bite
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
back injury
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
brain contusion
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
burns second degree
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
burns third degree
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
carbon monoxide poisoning
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
cartilage injury
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
cervical vertebral fracture
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
4 / 4943 (0.08%) |
occurrences causally related to treatment / all
|
0 / 1 |
1 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
chemical poisoning
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
clavicle fracture
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
concussion
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
4 / 4943 (0.08%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
contusion
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
6 / 4943 (0.12%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 6 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
coronary vascular graft occlusion
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
craniocerebral injury
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
7 / 4943 (0.14%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 7 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 2 |
craniofacial fracture
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
deep vein thrombosis postoperative
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
delayed recovery from anaesthesia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
facial bones fracture
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
failure to anastomose
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
fall
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
124 / 4949 (2.51%) |
110 / 4943 (2.23%) |
occurrences causally related to treatment / all
|
0 / 137 |
2 / 123 |
deaths causally related to treatment / all
|
0 / 2 |
0 / 0 |
femoral neck fracture
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
7 / 4949 (0.14%) |
4 / 4943 (0.08%) |
occurrences causally related to treatment / all
|
0 / 7 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
femur fracture
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
21 / 4949 (0.42%) |
18 / 4943 (0.36%) |
occurrences causally related to treatment / all
|
0 / 22 |
0 / 18 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
fibula fracture
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
5 / 4943 (0.10%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
foot fracture
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
forearm fracture
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
foreign body
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
foreign body aspiration
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
foreign body in gastrointestinal tract
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
gastroenteritis radiation
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
gastrointestinal injury
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
gastrointestinal stoma complication
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
graft thrombosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
gun shot wound
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
hand fracture
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
head injury
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
hip fracture
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
17 / 4949 (0.34%) |
12 / 4943 (0.24%) |
occurrences causally related to treatment / all
|
0 / 17 |
0 / 12 |
deaths causally related to treatment / all
|
0 / 2 |
0 / 0 |
humerus fracture
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
20 / 4949 (0.40%) |
12 / 4943 (0.24%) |
occurrences causally related to treatment / all
|
1 / 20 |
0 / 12 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
hyphaema
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
incisional hernia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
6 / 4949 (0.12%) |
6 / 4943 (0.12%) |
occurrences causally related to treatment / all
|
0 / 7 |
0 / 6 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
incisional hernia, obstructive
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
intentional overdose
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
intestinal anastomosis complication
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
jaw fracture
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
joint dislocation
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
5 / 4943 (0.10%) |
occurrences causally related to treatment / all
|
0 / 6 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
joint injury
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
laceration
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
4 / 4943 (0.08%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
ligament rupture
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
ligament sprain
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
limb crushing injury
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
limb injury
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
5 / 4943 (0.10%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
lower limb fracture
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
5 / 4943 (0.10%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
lumbar vertebral fracture
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
lumbosacral plexus injury
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
meniscus injury
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
12 / 4943 (0.24%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 12 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
multiple fractures
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
multiple injuries
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
muscle rupture
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
muscle strain
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
overdose
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
patella fracture
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
pelvic fracture
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
6 / 4943 (0.12%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 6 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
periprosthetic fracture
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
pneumothorax traumatic
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
post concussion syndrome
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
post procedural bile leak
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
post procedural complication
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
post procedural discharge
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
post procedural haematoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
post procedural haematuria
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
post procedural haemorrhage
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
7 / 4943 (0.14%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 7 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
post procedural swelling
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
post-traumatic pain
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
postoperative adhesion
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
postoperative delirium
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
postoperative thoracic procedure complication
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
postoperative wound complication
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
procedural hypotension
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
procedural pain
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
pubis fracture
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
radiation pneumonitis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
radius fracture
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
6 / 4949 (0.12%) |
8 / 4943 (0.16%) |
occurrences causally related to treatment / all
|
0 / 6 |
0 / 8 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
rib fracture
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
14 / 4949 (0.28%) |
10 / 4943 (0.20%) |
occurrences causally related to treatment / all
|
0 / 14 |
0 / 10 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
road traffic accident
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
9 / 4949 (0.18%) |
13 / 4943 (0.26%) |
occurrences causally related to treatment / all
|
0 / 10 |
0 / 13 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
scapula fracture
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
sciatic nerve injury
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
scrotal haematoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed [48]
|
1 / 2667 (0.04%) |
0 / 2640 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
skin injury
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
skull fracture
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
skull fractured base
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
soft tissue injury
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
spinal compression fracture
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
4 / 4943 (0.08%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
spinal cord injury cervical
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
spinal fracture
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
splenic rupture
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
stab wound
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
sternal fracture
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
stoma site haemorrhage
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
subarachnoid haemorrhage
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
7 / 4943 (0.14%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 7 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
subdural haematoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
7 / 4949 (0.14%) |
7 / 4943 (0.14%) |
occurrences causally related to treatment / all
|
0 / 7 |
0 / 8 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 2 |
subdural haemorrhage
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
suture rupture
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
tendon injury
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
tendon rupture
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
thermal burn
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
thoracic vertebral fracture
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
4 / 4943 (0.08%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
tibia fracture
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
8 / 4949 (0.16%) |
4 / 4943 (0.08%) |
occurrences causally related to treatment / all
|
0 / 8 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
tongue injury
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
toxicity to various agents
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
transfusion-related acute lung injury
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
traumatic fracture
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
traumatic haematoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
traumatic haemothorax
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
traumatic intracranial haemorrhage
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
ulna fracture
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
upper limb fracture
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
5 / 4943 (0.10%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
vascular graft occlusion
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
vascular pseudoaneurysm
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
4 / 4943 (0.08%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
wound
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
wound dehiscence
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
wound secretion
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
wrist fracture
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Congenital, familial and genetic disorders
|
|
|
adenomatous polyposis coli
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
atrial septal defect
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
chronic granulomatous disease
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
congenital cerebrovascular anomaly
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
developmental hip dysplasia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
exomphalos
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
gastrointestinal arteriovenous malformation
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
heart disease congenital
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
hereditary motor and sensory neuropathy
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
hydrocele
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed [49]
|
0 / 2667 (0.00%) |
2 / 2640 (0.08%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
hypertrophic cardiomyopathy
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
phimosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed [50]
|
1 / 2667 (0.04%) |
3 / 2640 (0.11%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
vascular malformation
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Cardiac disorders
|
|
|
acute coronary syndrome
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
41 / 4949 (0.83%) |
43 / 4943 (0.87%) |
occurrences causally related to treatment / all
|
0 / 43 |
0 / 44 |
deaths causally related to treatment / all
|
0 / 9 |
0 / 7 |
acute left ventricular failure
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
acute myocardial infarction
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
53 / 4949 (1.07%) |
39 / 4943 (0.79%) |
occurrences causally related to treatment / all
|
4 / 59 |
0 / 40 |
deaths causally related to treatment / all
|
0 / 14 |
0 / 15 |
angina pectoris
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
58 / 4949 (1.17%) |
56 / 4943 (1.13%) |
occurrences causally related to treatment / all
|
1 / 67 |
1 / 61 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
angina unstable
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
54 / 4949 (1.09%) |
44 / 4943 (0.89%) |
occurrences causally related to treatment / all
|
1 / 58 |
1 / 47 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
aortic valve disease mixed
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
aortic valve incompetence
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
5 / 4943 (0.10%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
aortic valve stenosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
6 / 4949 (0.12%) |
9 / 4943 (0.18%) |
occurrences causally related to treatment / all
|
0 / 7 |
0 / 9 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
arrhythmia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
6 / 4943 (0.12%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 6 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
arteriosclerosis coronary artery
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
9 / 4949 (0.18%) |
7 / 4943 (0.14%) |
occurrences causally related to treatment / all
|
0 / 9 |
0 / 7 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
atrial fibrillation
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
62 / 4949 (1.25%) |
90 / 4943 (1.82%) |
occurrences causally related to treatment / all
|
2 / 79 |
3 / 107 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
atrial flutter
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
18 / 4949 (0.36%) |
15 / 4943 (0.30%) |
occurrences causally related to treatment / all
|
1 / 19 |
1 / 19 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
atrial tachycardia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
atrial thrombosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
atrioventricular block
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
6 / 4949 (0.12%) |
7 / 4943 (0.14%) |
occurrences causally related to treatment / all
|
0 / 6 |
0 / 7 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
atrioventricular block complete
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
11 / 4949 (0.22%) |
8 / 4943 (0.16%) |
occurrences causally related to treatment / all
|
0 / 12 |
0 / 8 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
atrioventricular block first degree
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
atrioventricular block second degree
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
9 / 4949 (0.18%) |
8 / 4943 (0.16%) |
occurrences causally related to treatment / all
|
0 / 9 |
1 / 8 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
bifascicular block
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
bradyarrhythmia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
bradycardia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
10 / 4949 (0.20%) |
16 / 4943 (0.32%) |
occurrences causally related to treatment / all
|
0 / 10 |
0 / 17 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
bundle branch block left
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
bundle branch block right
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
cardiac arrest
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
14 / 4949 (0.28%) |
11 / 4943 (0.22%) |
occurrences causally related to treatment / all
|
0 / 15 |
0 / 14 |
deaths causally related to treatment / all
|
0 / 7 |
0 / 6 |
cardiac disorder
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
cardiac failure
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
104 / 4949 (2.10%) |
78 / 4943 (1.58%) |
occurrences causally related to treatment / all
|
3 / 124 |
2 / 87 |
deaths causally related to treatment / all
|
0 / 21 |
0 / 10 |
cardiac failure acute
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
9 / 4949 (0.18%) |
8 / 4943 (0.16%) |
occurrences causally related to treatment / all
|
0 / 10 |
0 / 11 |
deaths causally related to treatment / all
|
0 / 2 |
0 / 3 |
cardiac failure chronic
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
21 / 4949 (0.42%) |
14 / 4943 (0.28%) |
occurrences causally related to treatment / all
|
0 / 24 |
0 / 15 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
cardiac failure congestive
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
47 / 4949 (0.95%) |
38 / 4943 (0.77%) |
occurrences causally related to treatment / all
|
5 / 52 |
4 / 42 |
deaths causally related to treatment / all
|
0 / 4 |
0 / 8 |
cardiac tamponade
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
cardio-respiratory arrest
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
7 / 4949 (0.14%) |
5 / 4943 (0.10%) |
occurrences causally related to treatment / all
|
1 / 7 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 4 |
0 / 3 |
cardiogenic shock
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
5 / 4943 (0.10%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 2 |
cardiomyopathy
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
cardiomyopathy alcoholic
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
cardiopulmonary failure
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
cardiorenal syndrome
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
cardiovascular disorder
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
cardiovascular insufficiency
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
chronic left ventricular failure
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
congestive cardiomyopathy
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
7 / 4943 (0.14%) |
occurrences causally related to treatment / all
|
1 / 3 |
0 / 7 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
cor pulmonale
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
coronary artery disease
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
57 / 4949 (1.15%) |
57 / 4943 (1.15%) |
occurrences causally related to treatment / all
|
1 / 64 |
0 / 63 |
deaths causally related to treatment / all
|
0 / 2 |
0 / 0 |
coronary artery insufficiency
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
coronary artery occlusion
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
coronary artery perforation
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
coronary artery stenosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
5 / 4943 (0.10%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
defect conduction intraventricular
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
diastolic dysfunction
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
dressler's syndrome
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
extrasystoles
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
gastrocardiac syndrome
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
hypertensive heart disease
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
ischaemic cardiomyopathy
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
10 / 4943 (0.20%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 11 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
left ventricular dysfunction
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
left ventricular failure
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
8 / 4949 (0.16%) |
13 / 4943 (0.26%) |
occurrences causally related to treatment / all
|
0 / 8 |
0 / 13 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
metabolic cardiomyopathy
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
microvascular coronary artery disease
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
mitral valve disease
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
mitral valve incompetence
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
7 / 4949 (0.14%) |
9 / 4943 (0.18%) |
occurrences causally related to treatment / all
|
0 / 7 |
0 / 9 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
mitral valve prolapse
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
mitral valve stenosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
myocardial infarction
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
35 / 4949 (0.71%) |
30 / 4943 (0.61%) |
occurrences causally related to treatment / all
|
0 / 37 |
4 / 30 |
deaths causally related to treatment / all
|
0 / 8 |
2 / 8 |
myocardial ischaemia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
23 / 4949 (0.46%) |
19 / 4943 (0.38%) |
occurrences causally related to treatment / all
|
0 / 23 |
0 / 20 |
deaths causally related to treatment / all
|
0 / 2 |
0 / 1 |
myocarditis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
nodal rhythm
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
palpitations
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
pericardial effusion
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
pericarditis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
6 / 4949 (0.12%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 6 |
1 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
prinzmetal angina
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
right ventricular dysfunction
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
right ventricular failure
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
silent myocardial infarction
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
1 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
sinoatrial block
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
sinus arrest
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
sinus bradycardia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
6 / 4949 (0.12%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 6 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
sinus node dysfunction
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
9 / 4949 (0.18%) |
6 / 4943 (0.12%) |
occurrences causally related to treatment / all
|
0 / 9 |
0 / 6 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
sinus tachycardia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
stress cardiomyopathy
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
supraventricular extrasystoles
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
supraventricular tachycardia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
9 / 4949 (0.18%) |
7 / 4943 (0.14%) |
occurrences causally related to treatment / all
|
0 / 9 |
0 / 7 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
tachyarrhythmia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
tachycardia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 2 |
2 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
tachycardia induced cardiomyopathy
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
tricuspid valve incompetence
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
ventricular arrhythmia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
ventricular extrasystoles
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
4 / 4943 (0.08%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
ventricular fibrillation
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
4 / 4943 (0.08%) |
occurrences causally related to treatment / all
|
0 / 3 |
1 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
ventricular tachycardia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
7 / 4943 (0.14%) |
occurrences causally related to treatment / all
|
0 / 10 |
0 / 11 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Nervous system disorders
|
|
|
acoustic neuritis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
altered state of consciousness
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
1 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
amnesia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
amputation stump pain
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
aphasia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
ataxia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
1 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
autonomic nervous system imbalance
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
balance disorder
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
basal ganglia haemorrhage
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
brain injury
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
brain stem haemorrhage
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
brain stem infarction
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
carotid arteriosclerosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
carotid artery occlusion
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
carotid artery stenosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
9 / 4949 (0.18%) |
5 / 4943 (0.10%) |
occurrences causally related to treatment / all
|
0 / 10 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
carotid sinus syndrome
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
carpal tunnel syndrome
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
cauda equina syndrome
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
cerebellar ataxia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
cerebellar atrophy
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
cerebellar infarction
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
cerebral arteriosclerosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
cerebral atrophy
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
cerebral circulatory failure
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
cerebral haematoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
cerebral haemorrhage
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
cerebral infarction
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
5 / 4943 (0.10%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
cerebral ischaemia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
5 / 4943 (0.10%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
cerebrovascular accident
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
31 / 4949 (0.63%) |
24 / 4943 (0.49%) |
occurrences causally related to treatment / all
|
1 / 34 |
0 / 25 |
deaths causally related to treatment / all
|
1 / 2 |
0 / 1 |
cerebrovascular disorder
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
cerebrovascular insufficiency
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
cervical radiculopathy
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
cervicobrachial syndrome
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
cognitive disorder
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
coma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
dementia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
4 / 4943 (0.08%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
dementia alzheimer's type
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
demyelinating polyneuropathy
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
depressed level of consciousness
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
diabetic coma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
diabetic hyperglycaemic coma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
diabetic hyperosmolar coma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
diabetic mononeuropathy
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
diabetic neuropathy
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
8 / 4949 (0.16%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 8 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
dizziness
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
9 / 4943 (0.18%) |
occurrences causally related to treatment / all
|
0 / 2 |
1 / 9 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
dizziness postural
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
dysarthria
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
embolic stroke
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
encephalopathy
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
4 / 4943 (0.08%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
epilepsy
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
8 / 4949 (0.16%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 8 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
facial paralysis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
5 / 4943 (0.10%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
frontal lobe epilepsy
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
generalised tonic-clonic seizure
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
guillain-barre syndrome
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
haemorrhage intracranial
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
haemorrhagic cerebral infarction
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
haemorrhagic stroke
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
4 / 4943 (0.08%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
headache
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
1 / 2 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
hemiparesis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
hemiplegia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
hepatic encephalopathy
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
hydrocephalus
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 6 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
hypertensive encephalopathy
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
hypoaesthesia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
iiird nerve paralysis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
intracranial aneurysm
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
intracranial haematoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
ischaemic cerebral infarction
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
ischaemic neuropathy
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
ischaemic stroke
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
18 / 4949 (0.36%) |
14 / 4943 (0.28%) |
occurrences causally related to treatment / all
|
1 / 22 |
0 / 15 |
deaths causally related to treatment / all
|
0 / 5 |
0 / 1 |
lacunar infarction
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
lacunar stroke
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
language disorder
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
loss of consciousness
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
lumbar radiculopathy
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
lumbosacral radiculopathy
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
metabolic encephalopathy
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
5 / 4943 (0.10%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
migraine
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
mixed dementia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
monoparesis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
motor neurone disease
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
myasthenia gravis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
myelopathy
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
myoclonus
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
nerve root compression
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
nervous system disorder
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
neuritis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
neuropathy peripheral
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
5 / 4943 (0.10%) |
occurrences causally related to treatment / all
|
0 / 2 |
1 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
normal pressure hydrocephalus
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
optic neuritis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
paralysis recurrent laryngeal nerve
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
parkinson's disease
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 2 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
parkinsonism
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
partial seizures
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
peripheral nerve paresis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
peripheral sensorimotor neuropathy
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
peroneal nerve palsy
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
piriformis syndrome
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
polyneuropathy
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
post herpetic neuralgia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
presyncope
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
4 / 4943 (0.08%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
pseudobulbar palsy
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
psychomotor hyperactivity
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
quadriplegia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
radiculopathy
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
sciatica
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
7 / 4949 (0.14%) |
6 / 4943 (0.12%) |
occurrences causally related to treatment / all
|
0 / 8 |
0 / 6 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
seizure
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
7 / 4943 (0.14%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 7 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
sensory disturbance
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
serotonin syndrome
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
spinal claudication
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
syncope
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
33 / 4949 (0.67%) |
36 / 4943 (0.73%) |
occurrences causally related to treatment / all
|
1 / 34 |
5 / 38 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
thrombotic stroke
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
toxic encephalopathy
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
transient global amnesia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
transient ischaemic attack
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
23 / 4949 (0.46%) |
22 / 4943 (0.45%) |
occurrences causally related to treatment / all
|
0 / 24 |
0 / 25 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
tremor
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
trigeminal neuralgia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
uraemic encephalopathy
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
vith nerve paralysis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
vascular dementia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
vascular encephalopathy
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
vascular parkinsonism
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
vertebrobasilar insufficiency
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
wernicke's encephalopathy
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Blood and lymphatic system disorders
|
|
|
agranulocytosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
anaemia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
23 / 4949 (0.46%) |
29 / 4943 (0.59%) |
occurrences causally related to treatment / all
|
1 / 24 |
0 / 30 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
anaemia folate deficiency
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
anaemia macrocytic
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
anaemia of malignant disease
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
anaemia vitamin b12 deficiency
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
blood disorder
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
deficiency anaemia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
disseminated intravascular coagulation
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
febrile neutropenia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
haemolytic anaemia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
haemorrhagic anaemia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
histiocytosis haematophagic
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
hypochromic anaemia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
immune thrombocytopenic purpura
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
iron deficiency anaemia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
9 / 4949 (0.18%) |
14 / 4943 (0.28%) |
occurrences causally related to treatment / all
|
1 / 10 |
0 / 14 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
lymphadenopathy
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
lymphadenopathy mediastinal
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
microcytic anaemia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
nephrogenic anaemia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
neutropenia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
normochromic normocytic anaemia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
normocytic anaemia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
pancytopenia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
polycythaemia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
splenic haemorrhage
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
splenomegaly
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
thrombocytopenia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Ear and labyrinth disorders
|
|
|
deafness
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
deafness neurosensory
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
deafness unilateral
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
hypoacusis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
sudden hearing loss
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
vertigo
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
6 / 4949 (0.12%) |
4 / 4943 (0.08%) |
occurrences causally related to treatment / all
|
0 / 6 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
vertigo positional
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
4 / 4943 (0.08%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
vestibular ataxia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
vestibular disorder
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Eye disorders
|
|
|
amaurosis fugax
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
amblyopia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
angle closure glaucoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
blepharochalasis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
cataract
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
29 / 4949 (0.59%) |
19 / 4943 (0.38%) |
occurrences causally related to treatment / all
|
0 / 34 |
0 / 27 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
cataract diabetic
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
cataract nuclear
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
cataract subcapsular
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
dacryostenosis acquired
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
diabetic retinopathy
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 8 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
diplopia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
eye haemorrhage
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
glaucoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
6 / 4949 (0.12%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 6 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
hypermetropia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
iridodialysis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
lens dislocation
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
macular fibrosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
macular hole
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
macular oedema
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
maculopathy
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
neurotrophic keratopathy
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
open angle glaucoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
ophthalmic vein thrombosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
optic ischaemic neuropathy
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
retinal artery embolism
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
retinal artery occlusion
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
retinal detachment
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
retinal haemorrhage
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
retinal tear
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
strabismus
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
vitreous haemorrhage
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Gastrointestinal disorders
|
|
|
abdominal adhesions
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
abdominal compartment syndrome
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
abdominal discomfort
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
abdominal hernia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
7 / 4949 (0.14%) |
7 / 4943 (0.14%) |
occurrences causally related to treatment / all
|
0 / 7 |
0 / 7 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
abdominal hernia obstructive
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
abdominal incarcerated hernia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
abdominal mass
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
abdominal pain
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
10 / 4949 (0.20%) |
10 / 4943 (0.20%) |
occurrences causally related to treatment / all
|
1 / 11 |
1 / 12 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 2 |
abdominal pain upper
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
abdominal wall haematoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
1 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
acute abdomen
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
anal fistula
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
anal incontinence
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
ascites
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
barrett's oesophagus
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
chronic gastritis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
colitis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
7 / 4949 (0.14%) |
4 / 4943 (0.08%) |
occurrences causally related to treatment / all
|
0 / 9 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
colitis ischaemic
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
4 / 4943 (0.08%) |
occurrences causally related to treatment / all
|
0 / 3 |
1 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
colitis microscopic
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
1 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
colitis ulcerative
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
constipation
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
6 / 4949 (0.12%) |
6 / 4943 (0.12%) |
occurrences causally related to treatment / all
|
0 / 6 |
0 / 6 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
crohn's disease
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
dental cyst
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
diabetic gastroparesis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
diaphragmatic hernia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
diarrhoea
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
8 / 4949 (0.16%) |
10 / 4943 (0.20%) |
occurrences causally related to treatment / all
|
0 / 8 |
4 / 10 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
diverticular perforation
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
diverticulum
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
5 / 4943 (0.10%) |
occurrences causally related to treatment / all
|
0 / 2 |
1 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
diverticulum intestinal
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
5 / 4943 (0.10%) |
occurrences causally related to treatment / all
|
0 / 2 |
1 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
diverticulum intestinal haemorrhagic
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
1 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
duodenal ulcer
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
duodenal ulcer haemorrhage
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
duodenitis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
dyspepsia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
dysphagia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
enteritis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
enterovesical fistula
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
erosive duodenitis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
faecaloma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
1 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
fistula of small intestine
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
food poisoning
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
gallstone ileus
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
gastric dilatation
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
gastric dysplasia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
gastric haemorrhage
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
gastric polyps
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
gastric ulcer
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
7 / 4949 (0.14%) |
6 / 4943 (0.12%) |
occurrences causally related to treatment / all
|
0 / 7 |
0 / 6 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
gastric ulcer haemorrhage
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
8 / 4943 (0.16%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 8 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
gastritis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
17 / 4949 (0.34%) |
13 / 4943 (0.26%) |
occurrences causally related to treatment / all
|
1 / 17 |
3 / 13 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
gastritis erosive
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
1 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
gastroduodenitis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
gastrointestinal haemorrhage
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
13 / 4949 (0.26%) |
12 / 4943 (0.24%) |
occurrences causally related to treatment / all
|
1 / 14 |
1 / 13 |
deaths causally related to treatment / all
|
0 / 2 |
0 / 3 |
gastrointestinal inflammation
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
gastrointestinal motility disorder
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
gastrointestinal mucocoele
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
gastrointestinal necrosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
gastrointestinal polyp
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
gastrointestinal polyp haemorrhage
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
gastrointestinal ulcer
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
gastrointestinal ulcer haemorrhage
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
gastrointestinal vascular malformation haemorrhagic
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
gastrooesophageal reflux disease
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
6 / 4949 (0.12%) |
9 / 4943 (0.18%) |
occurrences causally related to treatment / all
|
0 / 6 |
0 / 9 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
haematemesis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
haematochezia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
haemorrhagic erosive gastritis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
haemorrhoidal haemorrhage
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
haemorrhoids
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
5 / 4943 (0.10%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
haemorrhoids thrombosed
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
hernial eventration
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
heyde's syndrome
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
hiatus hernia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
7 / 4943 (0.14%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 7 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
ileus
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
ileus paralytic
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
impaired gastric emptying
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
incarcerated inguinal hernia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
incarcerated umbilical hernia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
inguinal hernia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
11 / 4949 (0.22%) |
17 / 4943 (0.34%) |
occurrences causally related to treatment / all
|
0 / 11 |
0 / 17 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
intestinal haemorrhage
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
intestinal ischaemia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
intestinal mass
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
intestinal obstruction
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
14 / 4949 (0.28%) |
9 / 4943 (0.18%) |
occurrences causally related to treatment / all
|
1 / 15 |
2 / 9 |
deaths causally related to treatment / all
|
0 / 2 |
0 / 0 |
intestinal perforation
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
intestinal polyp
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
intestinal stenosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
intra-abdominal haemorrhage
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
intussusception
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
irritable bowel syndrome
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
large intestine perforation
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
1 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
large intestine polyp
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
4 / 4943 (0.08%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 6 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
lower gastrointestinal haemorrhage
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
6 / 4949 (0.12%) |
6 / 4943 (0.12%) |
occurrences causally related to treatment / all
|
0 / 6 |
0 / 6 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
mallory-weiss syndrome
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
mechanical ileus
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
megacolon
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
melaena
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
mesenteric arterial occlusion
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
mesenteric artery thrombosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
mouth haemorrhage
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
nausea
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
necrotising oesophagitis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
obstructive pancreatitis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
oesophageal achalasia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
oesophageal spasm
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
oesophageal stenosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
1 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
oesophageal varices haemorrhage
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
oesophagitis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
palatal disorder
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
pancreatic cyst
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
1 / 2 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
pancreatic pseudocyst
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
pancreatitis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
9 / 4943 (0.18%) |
occurrences causally related to treatment / all
|
1 / 5 |
5 / 9 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
pancreatitis acute
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
8 / 4949 (0.16%) |
15 / 4943 (0.30%) |
occurrences causally related to treatment / all
|
5 / 10 |
5 / 15 |
deaths causally related to treatment / all
|
1 / 1 |
0 / 0 |
pancreatitis chronic
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
peptic ulcer
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
peritoneal adhesions
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
peritoneal haematoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
peritoneal hernia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
portal venous gas
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
proctitis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
rectal haemorrhage
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
5 / 4943 (0.10%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
rectal polyp
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
retroperitoneal haemorrhage
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
salivary gland calculus
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
small intestinal obstruction
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
10 / 4949 (0.20%) |
5 / 4943 (0.10%) |
occurrences causally related to treatment / all
|
0 / 12 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
spigelian hernia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
strangulated umbilical hernia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
thrombosis mesenteric vessel
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
umbilical hernia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
7 / 4949 (0.14%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 7 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
umbilical hernia, obstructive
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
upper gastrointestinal haemorrhage
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
10 / 4949 (0.20%) |
7 / 4943 (0.14%) |
occurrences causally related to treatment / all
|
0 / 10 |
1 / 7 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
varices oesophageal
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
volvulus of small bowel
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
vomiting
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
6 / 4943 (0.12%) |
occurrences causally related to treatment / all
|
0 / 5 |
2 / 8 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Skin and subcutaneous tissue disorders
|
|
|
angioedema
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
1 / 3 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
decubitus ulcer
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
dermatitis allergic
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
dermatitis atopic
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
diabetic foot
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
19 / 4949 (0.38%) |
14 / 4943 (0.28%) |
occurrences causally related to treatment / all
|
0 / 24 |
0 / 17 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
diabetic neuropathic ulcer
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
diabetic ulcer
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
erythrodermic psoriasis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
hypersensitivity vasculitis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
1 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
ischaemic skin ulcer
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
neuropathic ulcer
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
pemphigoid
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
psoriasis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
pyoderma gangrenosum
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
rash generalised
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
rash papular
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
skin disorder
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
skin lesion
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
skin ulcer
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
15 / 4949 (0.30%) |
9 / 4943 (0.18%) |
occurrences causally related to treatment / all
|
0 / 16 |
0 / 13 |
deaths causally related to treatment / all
|
0 / 2 |
0 / 0 |
stasis dermatitis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
subcutaneous emphysema
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
urticaria
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
vasculitic ulcer
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Renal and urinary disorders
|
|
|
acute kidney injury
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
67 / 4949 (1.35%) |
61 / 4943 (1.23%) |
occurrences causally related to treatment / all
|
7 / 74 |
2 / 72 |
deaths causally related to treatment / all
|
1 / 7 |
1 / 2 |
atonic urinary bladder
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
azotaemia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
bladder dysfunction
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
bladder fibrosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
bladder hypertrophy
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
bladder mass
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
bladder neck obstruction
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
bladder neck sclerosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
bladder obstruction
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
bladder outlet obstruction
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
bladder pain
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
calculus bladder
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
5 / 4943 (0.10%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
calculus urethral
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
calculus urinary
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
chronic kidney disease
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
19 / 4949 (0.38%) |
13 / 4943 (0.26%) |
occurrences causally related to treatment / all
|
0 / 20 |
0 / 13 |
deaths causally related to treatment / all
|
0 / 2 |
0 / 0 |
cystitis haemorrhagic
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
diabetic nephropathy
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
dysuria
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
end stage renal disease
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
6 / 4949 (0.12%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
2 / 6 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
haematuria
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
7 / 4949 (0.14%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 8 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
haemorrhage urinary tract
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
hydronephrosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
hydroureter
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
hypertensive nephropathy
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
hypertonic bladder
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
kidney perforation
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
nephrolithiasis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
17 / 4949 (0.34%) |
18 / 4943 (0.36%) |
occurrences causally related to treatment / all
|
0 / 18 |
0 / 19 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
nephropathy
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
pelvi-ureteric obstruction
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
proteinuria
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
1 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
renal colic
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
6 / 4949 (0.12%) |
7 / 4943 (0.14%) |
occurrences causally related to treatment / all
|
0 / 7 |
1 / 8 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
renal cyst
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
renal failure
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
17 / 4949 (0.34%) |
16 / 4943 (0.32%) |
occurrences causally related to treatment / all
|
1 / 17 |
0 / 16 |
deaths causally related to treatment / all
|
1 / 6 |
0 / 4 |
renal haematoma
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
renal haemorrhage
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
renal impairment
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
6 / 4949 (0.12%) |
7 / 4943 (0.14%) |
occurrences causally related to treatment / all
|
0 / 6 |
0 / 8 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
renal infarct
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
renal mass
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
stress urinary incontinence
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
tubulointerstitial nephritis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
ureteric dilatation
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
ureteric stenosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
ureterolithiasis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
9 / 4949 (0.18%) |
9 / 4943 (0.18%) |
occurrences causally related to treatment / all
|
0 / 10 |
0 / 9 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
urethral caruncle
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
urethral disorder
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
urethral stenosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
4 / 4943 (0.08%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
urinary bladder polyp
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
urinary incontinence
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
urinary retention
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
9 / 4949 (0.18%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
1 / 9 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
urinary tract obstruction
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Endocrine disorders
|
|
|
acromegaly
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
adrenal insufficiency
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
adrenocortical insufficiency acute
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
autoimmune thyroiditis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
cushing's syndrome
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
goitre
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
8 / 4949 (0.16%) |
12 / 4943 (0.24%) |
occurrences causally related to treatment / all
|
0 / 8 |
1 / 12 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
hyperaldosteronism
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
hyperparathyroidism
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
hyperparathyroidism primary
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
hyperparathyroidism secondary
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
hyperthyroidism
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
hypoparathyroidism secondary
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
parathyroid disorder
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
primary hyperaldosteronism
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
thyroid mass
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
1 / 2 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
thyroiditis subacute
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
toxic nodular goitre
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Musculoskeletal and connective tissue disorders
|
|
|
arthralgia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
6 / 4949 (0.12%) |
9 / 4943 (0.18%) |
occurrences causally related to treatment / all
|
0 / 6 |
0 / 9 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
arthritis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
7 / 4949 (0.14%) |
6 / 4943 (0.12%) |
occurrences causally related to treatment / all
|
0 / 7 |
0 / 6 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
arthritis reactive
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
arthrofibrosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
arthropathy
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
articular calcification
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
back pain
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
9 / 4949 (0.18%) |
6 / 4943 (0.12%) |
occurrences causally related to treatment / all
|
0 / 10 |
0 / 6 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
bone lesion
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
bursitis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
cervical spinal stenosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
5 / 4943 (0.10%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
chondrocalcinosis pyrophosphate
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
chondromalacia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
chondropathy
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
costochondritis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
diabetic amyotrophy
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
diabetic arthropathy
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
dupuytren's contracture
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
exostosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
fistula
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
foot deformity
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
fracture malunion
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
gouty arthritis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
gouty tophus
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
intervertebral disc degeneration
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
intervertebral disc disorder
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
intervertebral disc protrusion
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
21 / 4949 (0.42%) |
15 / 4943 (0.30%) |
occurrences causally related to treatment / all
|
0 / 22 |
0 / 16 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
joint ankylosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
joint noise
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
joint swelling
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
lumbar spinal stenosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
11 / 4949 (0.22%) |
10 / 4943 (0.20%) |
occurrences causally related to treatment / all
|
0 / 14 |
0 / 10 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
mobility decreased
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
muscle haemorrhage
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
muscle spasms
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
muscular weakness
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
musculoskeletal chest pain
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
6 / 4949 (0.12%) |
10 / 4943 (0.20%) |
occurrences causally related to treatment / all
|
0 / 6 |
0 / 10 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
musculoskeletal pain
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
myalgia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
neck pain
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
neuropathic arthropathy
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
osteitis deformans
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
osteoarthritis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
110 / 4949 (2.22%) |
136 / 4943 (2.75%) |
occurrences causally related to treatment / all
|
0 / 128 |
0 / 155 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
osteochondrosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
4 / 4943 (0.08%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
osteonecrosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
4 / 4943 (0.08%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
osteopenia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
osteoporosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
pain in extremity
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
patellofemoral pain syndrome
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
pathological fracture
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
periarthritis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
plantar fascial fibromatosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
polymyalgia rheumatica
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
pseudarthrosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
rhabdomyolysis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
rheumatic disorder
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
rheumatoid arthritis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
rotator cuff syndrome
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
10 / 4949 (0.20%) |
8 / 4943 (0.16%) |
occurrences causally related to treatment / all
|
0 / 11 |
0 / 8 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
spinal column stenosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
7 / 4949 (0.14%) |
13 / 4943 (0.26%) |
occurrences causally related to treatment / all
|
0 / 7 |
0 / 13 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
spinal osteoarthritis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
21 / 4949 (0.42%) |
16 / 4943 (0.32%) |
occurrences causally related to treatment / all
|
0 / 23 |
0 / 19 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
spinal pain
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
5 / 4943 (0.10%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
spondylitis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
spondyloarthropathy
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
spondylolisthesis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
6 / 4943 (0.12%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 6 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
spondylolysis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
synovial cyst
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
synovitis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
tendon disorder
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
tendonitis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
tenosynovitis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
vertebral foraminal stenosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
vertebral osteophyte
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Infections and infestations
|
|
|
abdominal abscess
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
1 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
abscess
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
abscess intestinal
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
abscess limb
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
abscess neck
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
abscess oral
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
anal abscess
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
4 / 4943 (0.08%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
anal infection
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
aortitis salmonella
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
appendiceal abscess
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
appendicitis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
6 / 4943 (0.12%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 6 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
appendicitis perforated
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
arthritis bacterial
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
arthritis infective
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
atypical pneumonia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
bacteraemia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
6 / 4949 (0.12%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 6 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
bacterial infection
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
biliary sepsis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
brain abscess
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
breast abscess
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
breast cellulitis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
bronchitis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
12 / 4949 (0.24%) |
13 / 4943 (0.26%) |
occurrences causally related to treatment / all
|
0 / 12 |
0 / 13 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
bronchitis bacterial
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
bronchitis fungal
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
bronchitis viral
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
burn infection
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
campylobacter gastroenteritis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
candida sepsis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
candiduria
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
carbuncle
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
cellulitis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
42 / 4949 (0.85%) |
38 / 4943 (0.77%) |
occurrences causally related to treatment / all
|
0 / 48 |
0 / 39 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
cellulitis streptococcal
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
cervicitis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed [51]
|
0 / 2282 (0.00%) |
1 / 2303 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
cholecystitis infective
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
chronic hepatitis b
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
clostridium colitis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
clostridium difficile colitis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
5 / 4943 (0.10%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 6 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
clostridium difficile infection
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
corneal abscess
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
cystitis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
6 / 4949 (0.12%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 6 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
cystitis escherichia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
cytomegalovirus colitis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
dengue fever
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
dengue haemorrhagic fever
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
device related infection
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 6 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
device related sepsis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
diabetic foot infection
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
diabetic gangrene
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
diarrhoea infectious
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
diverticulitis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
10 / 4949 (0.20%) |
15 / 4943 (0.30%) |
occurrences causally related to treatment / all
|
0 / 12 |
1 / 17 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
dysentery
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
echinococciasis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
empyema
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
endocarditis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
4 / 4943 (0.08%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
endocarditis bacterial
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
enterococcal sepsis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
enterocolitis bacterial
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
epididymitis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed [52]
|
0 / 2667 (0.00%) |
4 / 2640 (0.15%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
erysipelas
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
15 / 4949 (0.30%) |
11 / 4943 (0.22%) |
occurrences causally related to treatment / all
|
0 / 18 |
0 / 12 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
escherichia bacteraemia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
escherichia sepsis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
1 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
escherichia urinary tract infection
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
extradural abscess
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
gallbladder abscess
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
gallbladder empyema
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
gangrene
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
11 / 4949 (0.22%) |
8 / 4943 (0.16%) |
occurrences causally related to treatment / all
|
0 / 11 |
0 / 18 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
gastroenteritis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
10 / 4949 (0.20%) |
21 / 4943 (0.42%) |
occurrences causally related to treatment / all
|
0 / 10 |
1 / 22 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
gastroenteritis clostridial
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
gastroenteritis norovirus
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
gastroenteritis viral
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
gastrointestinal infection
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
genitourinary tract infection
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
groin abscess
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
h1n1 influenza
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
haematoma infection
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
helicobacter gastritis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
helicobacter infection
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
hepatitis b
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
hepatitis c
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
hepatitis e
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
hepatitis infectious mononucleosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
herpes zoster
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
herpes zoster meningoencephalitis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
herpes zoster pharyngitis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
hydrocele male infected
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed [53]
|
0 / 2667 (0.00%) |
1 / 2640 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
implant site infection
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
infected skin ulcer
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
4 / 4943 (0.08%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
infection
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
infectious colitis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
infective exacerbation of chronic obstructive airways disease
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
6 / 4949 (0.12%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 8 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
influenza
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
8 / 4949 (0.16%) |
5 / 4943 (0.10%) |
occurrences causally related to treatment / all
|
0 / 8 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
injection site abscess
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
intervertebral discitis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
intestinal sepsis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
joint abscess
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
kidney infection
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
labyrinthitis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
laryngitis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
liver abscess
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
4 / 4943 (0.08%) |
occurrences causally related to treatment / all
|
0 / 1 |
1 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
localised infection
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
8 / 4949 (0.16%) |
8 / 4943 (0.16%) |
occurrences causally related to treatment / all
|
0 / 8 |
0 / 8 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
lower respiratory tract infection
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
11 / 4949 (0.22%) |
12 / 4943 (0.24%) |
occurrences causally related to treatment / all
|
0 / 12 |
0 / 13 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
lower respiratory tract infection bacterial
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
lower respiratory tract infection viral
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
lung abscess
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
lung infection
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
lymphangitis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
mastitis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
mastoiditis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
mediastinitis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
medical device site infection
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
medical device site joint infection
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
meningitis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
meningitis aseptic
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
myiasis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
necrotising fasciitis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
neutropenic sepsis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
oesophageal candidiasis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
orchitis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed [54]
|
2 / 2667 (0.07%) |
3 / 2640 (0.11%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
osteomyelitis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
11 / 4949 (0.22%) |
10 / 4943 (0.20%) |
occurrences causally related to treatment / all
|
0 / 13 |
0 / 11 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
osteomyelitis acute
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
osteomyelitis chronic
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
otitis externa
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
otitis media chronic
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
pancreatic abscess
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
paronychia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
pelvic abscess
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
pelvic infection
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
perihepatic abscess
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
perineal abscess
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
periodontitis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
perirectal abscess
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
peritonitis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
pharyngeal abscess
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
pneumonia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
151 / 4949 (3.05%) |
135 / 4943 (2.73%) |
occurrences causally related to treatment / all
|
0 / 174 |
1 / 152 |
deaths causally related to treatment / all
|
0 / 15 |
0 / 14 |
pneumonia bacterial
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
pneumonia influenzal
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
pneumonia klebsiella
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
pneumonia legionella
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
pneumonia streptococcal
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
1 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
pneumonia viral
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
post procedural infection
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
post procedural pneumonia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
post procedural sepsis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
postoperative abscess
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
postoperative wound infection
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
7 / 4943 (0.14%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 7 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
pseudomonal sepsis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
pulmonary mycosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
pulmonary sepsis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
4 / 4943 (0.08%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
pulmonary tuberculosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
pyelitis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
pyelonephritis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
15 / 4949 (0.30%) |
8 / 4943 (0.16%) |
occurrences causally related to treatment / all
|
0 / 15 |
0 / 8 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
pyelonephritis acute
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
8 / 4949 (0.16%) |
7 / 4943 (0.14%) |
occurrences causally related to treatment / all
|
0 / 8 |
0 / 7 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
pyelonephritis chronic
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
pyonephrosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
renal abscess
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
renal cyst infection
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
respiratory syncytial virus infection
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
respiratory tract infection
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
salmonella sepsis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
salmonellosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
scrotal infection
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed [55]
|
1 / 2667 (0.04%) |
0 / 2640 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
sepsis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
35 / 4949 (0.71%) |
30 / 4943 (0.61%) |
occurrences causally related to treatment / all
|
2 / 37 |
0 / 33 |
deaths causally related to treatment / all
|
1 / 7 |
0 / 4 |
septic shock
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
22 / 4949 (0.44%) |
15 / 4943 (0.30%) |
occurrences causally related to treatment / all
|
0 / 24 |
0 / 16 |
deaths causally related to treatment / all
|
0 / 9 |
0 / 5 |
sinusitis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
skin graft infection
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
skin infection
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
soft tissue infection
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
staphylococcal bacteraemia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
staphylococcal infection
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
staphylococcal mediastinitis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
staphylococcal sepsis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
staphylococcal skin infection
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
streptococcal bacteraemia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
subcutaneous abscess
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
3 / 4943 (0.06%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
subdiaphragmatic abscess
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
systemic candida
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
tooth abscess
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
tracheobronchitis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
tuberculosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
tuberculosis gastrointestinal
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
upper respiratory tract infection
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
urinary tract infection
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
61 / 4949 (1.23%) |
64 / 4943 (1.29%) |
occurrences causally related to treatment / all
|
2 / 65 |
0 / 78 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
urinary tract infection bacterial
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
urinary tract infection pseudomonal
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
urosepsis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
19 / 4949 (0.38%) |
24 / 4943 (0.49%) |
occurrences causally related to treatment / all
|
0 / 20 |
1 / 26 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 2 |
vestibular neuronitis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
4 / 4943 (0.08%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
viraemia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
viral infection
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
viral myocarditis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
wound infection
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
wound sepsis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Metabolism and nutrition disorders
|
|
|
abnormal loss of weight
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
cachexia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
decreased appetite
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
1 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
dehydration
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
14 / 4949 (0.28%) |
23 / 4943 (0.47%) |
occurrences causally related to treatment / all
|
0 / 15 |
3 / 24 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
diabetes mellitus
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
diabetes mellitus inadequate control
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
4 / 4943 (0.08%) |
occurrences causally related to treatment / all
|
1 / 3 |
1 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
diabetic ketoacidosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
6 / 4943 (0.12%) |
occurrences causally related to treatment / all
|
0 / 2 |
1 / 6 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
electrolyte imbalance
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
failure to thrive
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
fluid overload
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
food intolerance
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
gout
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
4 / 4949 (0.08%) |
4 / 4943 (0.08%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
hypercalcaemia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
1 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
hyperglycaemia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
67 / 4949 (1.35%) |
46 / 4943 (0.93%) |
occurrences causally related to treatment / all
|
3 / 75 |
0 / 52 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
hyperglycaemic hyperosmolar nonketotic syndrome
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
2 / 4949 (0.04%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
hyperkalaemia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
12 / 4949 (0.24%) |
8 / 4943 (0.16%) |
occurrences causally related to treatment / all
|
0 / 12 |
0 / 9 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
hyperosmolar state
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
hypocalcaemia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
hypoglycaemia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
72 / 4949 (1.45%) |
62 / 4943 (1.25%) |
occurrences causally related to treatment / all
|
34 / 80 |
31 / 69 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
hypokalaemia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
6 / 4943 (0.12%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 6 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
hypomagnesaemia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
2 / 4943 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
hyponatraemia
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
11 / 4949 (0.22%) |
8 / 4943 (0.16%) |
occurrences causally related to treatment / all
|
0 / 12 |
0 / 8 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
iron deficiency
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
ketoacidosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
1 / 4949 (0.02%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
lactic acidosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
0 / 4943 (0.00%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
metabolic acidosis
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
3 / 4949 (0.06%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
obesity
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
5 / 4949 (0.10%) |
5 / 4943 (0.10%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
type 2 diabetes mellitus
|
|
|
alternative dictionary used: MedDRA
21.0
|
|
|
subjects affected / exposed
|
0 / 4949 (0.00%) |
1 / 4943 (0.02%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |